PET scan before CABG in diabetes

British Journal of Diabetes and Vascular Disease

Volumn 7, Issue 1, 2007, Pages 32-37

  Hegazy, Hesham ^a   Refaei, Ayman ^a   Assedique, Azza ^a   Alsaif, Shukri ^a   Taha, Mayada ^a   Refaei, Mostafa ^a   Elkum, Nasser ^a   Alomran, Hamed ^a   Al Halees, Zohair ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Bypass surgery; Coronary artery disease; Diabetes; Hibernating myocardium; Impaired left ventricular function

Indexed keywords

BISMUTH GERMINIUM 68; FLUORODEOXYGLUCOSE F 18; INSULIN; RADIOISOTOPE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DRUG METABOLISM; DRUG UPTAKE; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE METABOLISM; HEART PERFUSION; HOSPITAL DISCHARGE; HUMAN; MALE; MYOCARDIAL HIBERNATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PREOPERATIVE EVALUATION; TREATMENT OUTCOME;

EID: 33947279964     PISSN: 14746514     EISSN: None     Source Type: Journal    
DOI: 10.1177/14746514070070010601     Document Type: Article

References (25)

1. Remme WJ, Swedberg K. Task force for the diagnosis and treatment of chronic heart disease, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22: 1527-60.
2. Cohn JN, Johnson GR, Shabeti R et al. Ejection fraction, peak exercise oxygen consumption cardiothoracic ratio as determinants of prognosis in heart failure. Circ 1993;87:v1-6-v1-16.
3. Trachiotis GD, Weintraub WS, Johnston TS et al. Coronary artery by pass grafting in patients with left ventricular dysfunction. Ann Thoracic Surg 1998;66:1632-9.
4. Nemec P, Bedanova H, Necolas J et al. Coronary artery bypass grafting in patients with left ventricular ejection fraction of 30% or less. Brastil Lek Listy 2001;102(1):15-21.
5. Luciani GB, Montalbano G, Casali G et al. Predicting long term functional results after myocardial revascularization in ischemic cardiomyopathy. J Thoracic Cardiovasc Surg 2000;120:478-89.
6. Topkara VK, Cheema FH, Kesavaramanujam S et al. Coronary artery bypass grafting in patients with low EF. Circ 2002;112(suppl 9):1344-50.
7. Alexanderson E. Usefullness of nuclear technique in the study of myocardial viability. Arch Cardiol Mex 2004;74(suppl 1):S8-S12.
8. Rahimtoola S. The hibernating myocardium. Am Heart J 1989;117:211-21.
9. Clenland JG, Pennel Dj, Ray SG et al. Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure. Lancet 2002;362:14-21.
10. Pezard P, Jallet P. Myocardial viability: study of viability by myocardial scintigraphy. Press Med 1998;27:1043-9.
11. Ghesani M, Depuey FG, R Zanski A. Role of F-18 FDG positron emission tomography in the assessment of myocardial viability. Echocardiogr 2005;22:165-77.
12. Koszegi Z, Galuskal L, Szakal S Jr et al. The role of PET scan among cardiologic imaging methods. Orv Hetol 2002;143(suppl 3):1314-16.
13. Giorgetti A, Marzullo P, Sambuceti G et al. Baseline/post nitrate Tc-99m tetrofosmine mismatch for the assessment of myocardial viability in patients with severe left ventricular dysfunction: comparison with baseline Tc-99m tetrofosmine scintigraphy/FDG PET imaging. J Nucl Cardiol 2004;11:142-51.
14. Maddahi J, Schelbert H, Brunken R et al. Role of TI-201 and PET imaging in evaluation of myocardial viability and management of patients with coronary artery disease and left ventricular dysfunction. J Nucl Med 1994;3S:707-15.
15. Schelbet H. Metabolic imaging to assess myocardial viability. J Nucl Med 1994;35(suppl):5S-14S.
16. Thourani VH, Weintraub WS, Stien B et al. Influence of DM on early and late outcome after coronary artery bypass grafting. Ann Thoracic Surg 1999;67:1045-52.
17. Bax JJ, Veening MA, Visserf C et al. Optimal metabolic conditions during FDG imaging: A comparative study between different protocols. Eur J Nucl Med 1997;24:35-41.
18. Von Dahi J, Herman WH, Hicks RJ et al. Myocardial glucose uptake in patients with insulin dependent diabetes mellitus assessed quantitatively by dynamic positrone emission tomography. Circ 1997;88:395-404.
19. Bax JJ Visser FC, Poldman D et al. Feasibility, safety and image quality of cardiac PET imaging study during hyperinsulinemic-euglycemic clamping. Eur J Nucl Med Mol Imaging 2002;29:452-7.
20. Schinkel Af, Bax JJ, Valkema R et al. Effect of DM on myocardial 18-F-FDG SPECT using Acipimox for assessment of myocardial viability. J Nucl Med 2003;44:877-83.
21. Bacharach SL, Bax JJ, Case J et al. PET myocardial glucose metabolism and perfusion imaging. Part 1: Guidelines for patient preparation and data acquisition. J Nucl Card 2003;10:543-54.
22. Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle function by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
23. Lucignani G, Andoni C, Paolini G et al. PET for assessment of myocardial viability: a synopsis of methods and indications. Rays 1999;24(1):81-95.
24. Bouchart F, Tabley A, Litzer Py et al. Myocardial revascularization in patients with severe ischemic left ventricular dysfunction: Long term follow up in 141 patients. Eur J Cardiothoracic Surg 2001;20:1157-62.
25. Flaming WJ, Shivalkar B, Spiessens B et al. PET scan predicts recovery of the left ventricular function after coronary artery bypass. Ann Thorac Surg 1997;64:1695-701.